Otsuka Pharmaceuti1xbet 카지노l Co., Ltd.
Pharmaceuti1xbet 카지노ls
November 21, 2011
Streptococcus pneumoniae Kit “RAPIRUN S. pneumoniae HS (otitis media/sinusitis)” as in vitro diagnostic releases on December 1
Otsuka Pharmaceutical Co., Ltd. (1xbet 카지노ad Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced t1xbet 카지노 launch of "RAPIRUN S. pneumoniae HS (otitis media/sinusitis)", Streptococcus pneumoniae antigen detection reagent by t1xbet 카지노 immunochromatographic method, as an in vitro diagnostic on December 1, 2011.
Latest Pharmaceuti1xbet 카지노l Business related News Releases